Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147) The study analyzed cancer-specific survival among 5.3 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results